Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam in Clinical Isolates of Pseudomonas Aeruginosa and Enterobacterales Collected From Hematology and Oncology Patients

NCT04196608 is registered in ClinicalTrials.gov with Emilio Bouza as lead sponsor.

NCT NCT04196608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04196608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam in Clinical Isolates of Pseudomonas Aeruginosa and Enterobacterales Collected From Hematology and Oncology Patients
Lead sponsor
Emilio Bouza
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
September 30, 2020
Enrollment
1,005 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ceftolozane/tazobactam, hematology and oncology, imipenem/relebactam